hMG addition affects the change in progesterone level during IVF stimulation and LBR: a retrospective cohort study

Table 1 Patient Demographics

Infertility Dx	n	Age (years)	BMI (kg/m²)	AMH (ng/mL)	Final E2 (pg/mL)	Total Follicles	Follicles > 15 mm	Total # Oocyte Retrieved
Male	78	37.61 ± 3.21	25.62 ± 5.18	2.55 ± 2.71	1935 ± 791	12.13 ± 5.33	6.46 ± 6 46	10.67 ± 5.26
Unexplained	63	34.82 ± 3.26	25.79 ± 5.27	2.88 ± 2.02	2127 ± 865	14.30 ± 6.74	7.42 ± 3.37	12.62 ± 6.66
Tubal	51	34.15 ± 4.00	27.98 ± 5.87	3.33 ± 3.30	1979 ± 786	13.07 ± 6.21	6.67 ± 3.23	11.29 ± 5.90
PCOS	36	33.66 ± 4.38	30.13 ± 5.61	5.78 ± 3.92	2258 ± 1036	17.31 ± 6.07	8.31 ± 3.07	13.83 ± 6.42
DOR	31	37.61 ± 3.21	24.78 ± 4.33	0.53 ± 0.37	1362 ± 864	7.61 ± 4.26	3.97 ± 2.09	5.97 ± 3.55
*Other	18	35.17 ± 4.38	26.06 ± 5.59	2.03 ± 1.81	1839 ± 907	10.95 ± 5.32	5.56 ± 2.29	10.22 ± 7.77
Ovulatory	14	34.42 ± 2.90	28.4 ± 6.48	3.46 ± 2.79	2263 ± 1192	14.50 ± 6.20	7.36 ± 3.52	9.42 ± 4.52

AMH – Anti-Mullerian Hormone, E2 – estradiol, PCOS - Polycystic Ovarian Syndrome; DOR – Diminished Ovarian Reserve; *Other included:2 same sex, 1 genetic, 5 endometriosis, 3 recurrent pregnancy loss (RPL), 2 uterine factor

ISSN: 1477-7827